Form 4: AbCellera Biologics CFO Buys Shares
Insider Transaction (Form 4)
Andrew Booth, Chief Financial Officer of AbCellera Biologics Inc., purchased 37,200 shares of common stock on August 14, 2026 for $10.32 per share.
Summary
- Open-market purchase: acquired 37,200 Common Shares at $10.32 ($383,904) on August 14, 2026; holds 482,800 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $383,904, committing personal capital to the stock.
Insider Transactions
Andrew Booth — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Common Shares | 37,200 | $10 | $383.9K | 482,800 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (37,200 shares) |
Keywords
insider transaction, Form 4, ABCL, AbCellera Biologics Inc., bullish, Andrew Booth
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.